Titan Pharmaceuticals, Inc. TTNP
Set alert
2.34 0.00 0.00%
As of Dec 16, 1:46 PM ET
2.30 Day range 2.69
3.14 52-week range 14.80
- YTD
- -28.22%
- 1 year
- -55.09%
- Open
- 2.55
- Prev close
- 2.34
- Mkt cap
- 2.96M
- Vol
- 131.90K
- Avg vol
- 18.01K
- EPS
- -6.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.30
- High
- 2.69
- Forward P/E
- -3.56
- Beta
- 1.13
- Short ratio
- 0.66
- Inst. own
- 1.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 24, 2024
- 50-d avg
- 3.97
- 200-d avg
- 5.73
- 1y target
- 0.00
2Y chart
Events in this range
- Nov 14, 2023Earnings: -0.4; estimate 0; surprise —%
- Jan 9, 2024Split: 1 for 20
- May 15, 2024Earnings: -1.24; estimate 0; surprise —%
- Aug 15, 2024Earnings: -2.29; estimate 0; surprise —%
- Dec 24, 2024Earnings: —; estimate 0; surprise —%
Signals (131)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Sep 30, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 30, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 25, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 24, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 23, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 18, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 16, 2025 | 1 year ago |
| SMA: Bearish | Sep 11, 2025 | 1 year ago |
| SMA: Bullish | Sep 10, 2025 | 1 year ago |
| SMA: Bullish | Sep 3, 2025 | 1 year ago |
| SMA: Bearish | Aug 28, 2025 | 1 year ago |
| SMA: Bearish | Aug 28, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 28, 2025 | 1 year ago |
| SMA: Bullish | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 12, 2025 | 1 year ago |
| SMA: Bullish | Aug 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 25, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 17, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 9, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 20, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 6, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 5, 2025 | 1 year ago |
| MACD: Sell Signal | May 20, 2025 | 1 year ago |
| SMA: Bullish | May 8, 2025 | 1 year ago |
| RSI: Overbought | May 8, 2025 | 1 year ago |
| MACD: Buy Signal | May 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 29, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 29, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| SMA: Bearish | Apr 25, 2025 | 1 year ago |
| SMA: Bullish | Apr 24, 2025 | 1 year ago |
| SMA: Bearish | Apr 17, 2025 | 1 year ago |
| SMA: Bullish | Apr 16, 2025 | 1 year ago |
| SMA: Bearish | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Apr 11, 2025 | 1 year ago |
| SMA: Bullish | Apr 10, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 28, 2025 | 1 year ago |
| SMA: Bullish | Mar 27, 2025 | 1 year ago |
| SMA: Bearish | Mar 26, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 21, 2025 | 1 year ago |
| SMA: Bullish | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Mar 6, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 6, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 26, 2025 | 1 year ago |
| SMA: Bullish | Feb 25, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 7, 2025 | 1 year ago |
| SMA: Bullish | Feb 5, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 31, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 23, 2025 | 1 year ago |
| SMA: Bearish | Jan 21, 2025 | 1 year ago |
| SMA: Bullish | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 24, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 11, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 21, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 20, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 5, 2024 | 1 year ago |
| RSI: Oversold | Oct 24, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 7, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 4, 2024 | 2 years ago |
| SMA: Bearish | Sep 6, 2024 | 2 years ago |
| SMA: Bullish | Sep 4, 2024 | 2 years ago |
| SMA: Bearish | Sep 3, 2024 | 2 years ago |
| SMA: Bullish | Aug 30, 2024 | 2 years ago |
| SMA: Bearish | Aug 29, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 29, 2024 | 2 years ago |
| SMA: Bearish | Aug 28, 2024 | 2 years ago |
| SMA: Bullish | Aug 27, 2024 | 2 years ago |
| SMA: Bearish | Aug 23, 2024 | 2 years ago |
| SMA: Bullish | Aug 20, 2024 | 2 years ago |
| SMA: Bullish | Aug 20, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 20, 2024 | 2 years ago |
| RSI: Overbought | Aug 20, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 14, 2024 | 2 years ago |
| SMA: Bearish | Aug 12, 2024 | 2 years ago |
| SMA: Bullish | Aug 9, 2024 | 2 years ago |
| SMA: Bearish | Jul 22, 2024 | 2 years ago |
| SMA: Bullish | Jul 19, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 17, 2024 | 2 years ago |
| RSI: Oversold | Jul 12, 2024 | 2 years ago |
| RSI: Oversold | Jul 9, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 26, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
| SMA: Bullish | Jun 11, 2024 | 2 years ago |
| MACD: Buy Signal | May 30, 2024 | 2 years ago |
| MACD: Sell Signal | May 24, 2024 | 2 years ago |
| MACD: Buy Signal | May 23, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 23, 2024 | 2 years ago |
| SMA: Bearish | Apr 22, 2024 | 2 years ago |
| SMA: Bullish | Apr 19, 2024 | 2 years ago |
| SMA: Bearish | Apr 17, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 12, 2024 | 2 years ago |
| SMA: Bullish | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 3, 2024 | 2 years ago |
| SMA: Bullish | Mar 26, 2024 | 2 years ago |
| SMA: Bearish | Mar 20, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 19, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 15, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 5, 2024 | 2 years ago |
| SMA: Bullish | Feb 8, 2024 | 2 years ago |
| SMA: Bearish | Feb 5, 2024 | 2 years ago |
| SMA: Bullish | Feb 2, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 2, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 12, 2024 | 2 years ago |
| SMA: Bearish | Jan 10, 2024 | 2 years ago |
| RSI: Overbought | Jan 5, 2024 | 2 years ago |
| SMA: Bullish | Dec 29, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 22, 2023 | 2 years ago |
| RSI: Oversold | Dec 8, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 27, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 24, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 17, 2023 | 2 years ago |
Key statistics
- Market cap
- 2.96M
- Enterprise value
- -1.00M
- Trailing P/E
- 0.00
- Forward P/E
- -3.56
- PEG ratio
- 0.00
- Price / sales
- 987.37
- Price / book
- 0.74
- EPS (TTM)
- -6.64
- Beta
- 1.13
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 3.00K
- Revenue growth
- 0.00%
- Free cash flow
- -5.21M
- Total cash
- 4.09M
- Total debt
- 0
- Return on equity
- -368.99%
- Shares outstanding
- 914.23K
- Short % of float
- 1.23%
- 50-day average
- 3.97
- 200-day average
- 5.73
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Dec 24, 2024
Expected Dec 24, 2024. Consensus EPS estimate 0.00.
Financials — quick view
TTNP Revenue — quarterly 0
TTNP Net income — quarterly -689.00K
TTNP EPS — quarterly -0.65
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 24, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 15, 2024 | Jun 1, 2024 | 0.00 | -2.29 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -1.24 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -0.40 | — | — |
| Nov 14, 2022 | Sep 1, 2022 | 0.00 | — | — | — |
About Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- titanpharm.com
News
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings
- Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
Your note
Sign in to keep a note on TTNP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEN-TZVI AVRAHAM | Director | Stock Award(Grant) | Oct 24, 2023 | 66,250 |
| CHASEY PETER LOUIS | Director | Stock Award(Grant) | Jul 25, 2023 | 50,000 |
| CHOONG CHOON HAU | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Mar 17, 2024 | 3,802,100 |
| GREENBERG ERIC HOWARD | Director | Stock Award(Grant) | Oct 24, 2023 | 66,250 |
| LAZAR DAVID ELLIOT | Chief Executive Officer | Stock Award(Grant) | Jul 25, 2023 | 100,000 |
| MCMURDO MATTHEW CHARLES | Director | Stock Award(Grant) | Oct 24, 2023 | 66,250 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 1.21% | 11,066 | 35.85K | Sep 29, 2024 |
| UBS Group AG | 0.52% | 4,773 | 15.46K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.08% | 743 | 2.41K | Sep 29, 2024 |
| MCF Advisors LLC | 0.02% | 165 | 534 | Sep 29, 2024 |
| Global Wealth Strategies & Associates | 0.00% | 2 | 6 | Sep 29, 2024 |
| Osaic Holdings Inc | 0.00% | 10 | 32 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.45% | 4,103 | 13.29K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.34% | 3,146 | 10.19K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.11% | 963 | 3.12K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.10% | 954 | 3.09K | Oct 30, 2024 |